Literature DB >> 20433550

Could baroreceptor activation therapy be the future for treating hypertension and other chronic cardiovascular conditions?

C Venkata S Ram1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20433550      PMCID： PMC8673221          DOI： 10.1111/j.1751-7176.2009.00252.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  10 in total

1.  TREATMENT OF HYPERTENSION WITH AN IMPLANTABLE ELECTRONIC DEVICE.

Authors:  A M BILGUTAY; C W LILLEHEI
Journal:  JAMA       Date:  1965-02-22       Impact factor: 56.272

2.  Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity?

Authors:  Qi Fu; Rong Zhang; Sarah Witkowski; Armin Arbab-Zadeh; Anand Prasad; Kazunobu Okazaki; Benjamin D Levine
Journal:  Hypertension       Date:  2005-02-28       Impact factor: 10.190

3.  Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Drew A Hildebrandt; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2005-10-10       Impact factor: 10.190

4.  Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure.

Authors:  Thomas E Lohmeier; Drew A Hildebrandt; Terry M Dwyer; Austin M Barrett; Eric D Irwin; Martin A Rossing; Robert S Kieval
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

5.  Prolonged activation of the baroreflex abolishes obesity-induced hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Eric D Irwin; Martin A Rossing; Robert S Kieval
Journal:  Hypertension       Date:  2007-04-16       Impact factor: 10.190

6.  Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure.

Authors:  Irving H Zucker; Johnnie F Hackley; Kurtis G Cornish; Bradley A Hiser; Nicholas R Anderson; Robert Kieval; Eric D Irwin; David J Serdar; Jacob D Peuler; Martin A Rossing
Journal:  Hypertension       Date:  2007-09-10       Impact factor: 10.190

7.  Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves.

Authors:  E Braunwald; S E Epstein; G Glick; A S Wechsler; N S Braunwald
Journal:  N Engl J Med       Date:  1967-12-14       Impact factor: 91.245

8.  Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.

Authors:  Kerstin Wustmann; Jan P Kucera; Ingrid Scheffers; Markus Mohaupt; Abraham A Kroon; Peter W de Leeuw; Jürg Schmidli; Yves Allemann; Etienne Delacrétaz
Journal:  Hypertension       Date:  2009-07-20       Impact factor: 10.190

9.  Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients.

Authors:  Dileep V Menon; Debbie Arbique; Zhongyun Wang; Beverley Adams-Huet; Richard J Auchus; Wanpen Vongpatanasin
Journal:  J Clin Endocrinol Metab       Date:  2009-01-21       Impact factor: 5.958

Review 10.  Lacidipine: a review of its use in the management of hypertension.

Authors:  Paul L McCormack; Antona J Wagstaff
Journal:  Drugs       Date:  2003       Impact factor: 9.546
  10 in total
  1 in total

1.  "Refractory" resistant hypertension: new terminology for an old problem.

Authors:  C Venkata S Ram; Russell L Silverstein
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12-07       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.